Novel P2 promoter-derived HNF4α isoforms with different N-terminus generated by alternate exon insertion

Experimental Cell Research

Volumn 315, Issue 7, 2009, Pages 1200-1211

  Huang, Jianmin ^a   Levitsky, Lynne L ^a   Rhoads, David B ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alternative splicing; Diabetes; Evolutionary conservation; Exon 1E; HNF4 ; HNF4 10 11 12; P2 promoter; Transcription factor; Variant isoform

Indexed keywords

DNA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA10; HEPATOCYTE NUCLEAR FACTOR 4ALPHA12; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; EMBRYO; EXON; FEMALE; GENE INSERTION SEQUENCE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; P2 PROMOTER; PANCREAS ISLET; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION;

RODENTIA;

ANIMALS; APOLIPOPROTEINS C; BASE SEQUENCE; CELL LINE; DIABETES MELLITUS, TYPE 2; EXONS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENETIC PREDISPOSITION TO DISEASE; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; SEQUENCE ALIGNMENT;

EID: 63049104215     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2009.01.004     Document Type: Article

References (53)

1. Sonoda J., Pei L., and Evans R.M. Nuclear receptors: decoding metabolic disease. FEBS Lett. 582 (2008) 2-9
2. Odom D.T., Zizlsperger N., Gordon D.B., Bell G.W., Rinaldi N.J., Murray H.L., Volkert T.L., Schreiber J., Rolfe P.A., Gifford D.K., Fraenkel E., Bell G.I., and Young R.A. Control of pancreas and liver gene expression by HNF transcription factors. Science 303 (2004) 1378-1381
3. Chen W.S., Manova K., Weinstein D.C., Duncan S.A., Plump A.S., Prezioso V.R., Bachvarova R.F., and Darnell Jr. J.E. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes Dev. 8 (1994) 2466-2477
4. Duncan S.A., Manova K., Chen W.S., Hoodless P., Weinstein D.C., Bachvarova R.F., and Darnell Jr. J.E. Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 7598-7602
5. Huang J., Karakucuk V., Levitsky L.L., and Rhoads D.B. Expression of HNF4alpha variants in pancreatic islets and Ins-1 beta cells. Diabetes Metab. Res. Rev. 24 (2008) 533-543
6. Kyrmizi I., Hatzis P., Katrakili N., Tronche F., Gonzalez F.J., and Talianidis I. Plasticity and expanding complexity of the hepatic transcription factor network during liver development. Genes Dev. 20 (2006) 2293-2305
7. Hansen S.K., Parrizas M., Jensen M.L., Pruhova S., Ek J., Boj S.F., Johansen A., Maestro M.A., Rivera F., Eiberg H., Andel M., Lebl J., Pedersen O., Ferrer J., and Hansen T. Genetic evidence that HNF-1a-dependent transcriptional control of HNF-4a is essential for human pancreatic beta cell function. J. Clin. Invest. 110 (2002) 827-833
8. Eeckhoute J., Moerman E., Bouckenooghe T., Lukoviak B., Pattou F., Formstecher P., Kerr-Conte J., Vandewalle B., and Laine B. Hepatocyte nuclear factor 4a isoforms originated from the P1 promoter are expressed in human pancreatic b-cells and exhibit stronger transcriptional potentials than P2 promoter-driven isoforms. Endocrinology 144 (2003) 1686-1694
9. Kamiya A., Inoue Y., and Gonzalez F.J. Role of the hepatocyte nuclear factor 4a in control of the pregnane X receptor during fetal liver development. Hepatology 37 (2003) 1375-1384
10. Harries L.W., Locke J.M., Shields B., Hanley N.A., Hanley K.P., Steele A., Njolstad P.R., Ellard S., and Hattersley A.T. The diabetic phenotype in HNF4A mutation carriers is moderated by the expression of HNF4A isoforms from the P1 promoter during fetal development. Diabetes 57 (2008) 1745-1752
11. Wang H., Maechler P., Antinozzi P.A., Hagenfeldt K.A., and Wollheim C.B. Hepatocyte nuclear factor 4a regulates the expression of pancreatic b-cell genes implicated in glucose metabolism and nutrient-induced insulin secretion. J. Biol. Chem. 275 (2000) 35953-35959
12. Ferrer J. A genetic switch in pancreatic b-cells: implications for differentiation and haploinsufficiency. Diabetes 51 (2002) 2355-2362
13. Yamagata K., Furuta H., Oda N., Kaisaki P.J., Menzel S., Cox N.J., Fajans S.S., Signorini S., Stoffel M., and Bell G.I. Mutations in the hepatocyte nuclear factor-4a gene in maturity-onset diabetes of the young (MODY1). Nature 384 (1996) 458-460
14. Furuta H., Iwasaki N., Oda N., Hinokio Y., Horikawa Y., Yamagata K., Yano N., Sugahiro J., Ogata M., Ohgawara H., Omori Y., Iwamoto Y., and Bell G.I. Organization and partial sequence of the hepatocyte nuclear factor-4a/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 46 (1997) 1652-1657
15. Ellard S., and Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1a (HNF1A) and 4a (HNF4A) in maturity-onset diabetes of the young. Hum. Mutat. 27 (2006) 854-869
16. Fajans S.S., Bell G.I., and Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345 (2001) 971-980
17. Thomas H., Jaschkowitz K., Bulman M., Frayling T.M., Mitchell S.M., Roosen S., Lingott-Frieg A., Tack C.J., Ellard S., Ryffel G.U., and Hattersley A.T. A distant upstream promoter of the HNF-4a gene connects the transcription factors involved in maturity-onset diabetes of the young. Hum. Mol. Genet. 10 (2001) 2089-2097
18. Love-Gregory L., and Permutt M.A. HNF4A genetic variants: role in diabetes. Curr. Opin. Clin. Nutr. Metab. Care 10 (2007) 397-402
19. Gupta R.K., and Kaestner K.H. HNF-4a: from MODY to late-onset type 2 diabetes. Trends Mol. Med. 10 (2004) 521-524
20. Mohlke K.L., and Boehnke M. The role of HNF4A variants in the risk of type 2 diabetes. Curr. Diab. Rep. 5 (2005) 149-156
21. Bonnycastle L.L., Willer C.J., Conneely K.N., Jackson A.U., Burrill C.P., Watanabe R.M., Chines P.S., Narisu N., Scott L.J., Enloe S.T., Swift A.J., Duren W.L., Stringham H.M., Erdos M.R., Riebow N.L., Buchanan T.A., Valle T.T., Tuomilehto J., Bergman R.N., Mohlke K.L., Boehnke M., and Collins F.S. Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns. Diabetes 55 (2006) 2534-2540
22. Malecki M.T. Genetics of type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 68 Suppl1 (2005) S10-S21
23. Sladek F.M., Zhong W.M., Lai E., and Darnell Jr. J.E. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4 (1990) 2353-2365
24. Hata S., Tsukamoto T., and Osumi T. A novel isoform of rat hepatocyte nuclear factor 4 (HNF-4). Biochim. Biophys. Acta 1131 (1992) 211-213
25. Kritis A.A., Argyrokastritis A., Moschonas N.K., Power S., Katrakili N., Zannis V.I., Cereghini S., and Talianidis I. Isolation and characterization of a third isoform of human hepatocyte nuclear factor 4. Gene 173 (1996) 275-280
26. Nakhei H., Lingott A., Lemm I., and Ryffel G.U. An alternative splice variant of the tissue specific transcription factor HNF4a predominates in undifferentiated murine cell types. Nucleic Acids Res. 26 (1998) 497-504
27. Ihara A., Yamagata K., Nammo T., Miura A., Yuan M., Tanaka T., Sladek F.M., Matsuzawa Y., Miyagawa J., and Shimomura I. Functional characterization of the HNF4a isoform (HNF4a8) expressed in pancreatic b-cells. Biochem. Biophys. Res. Commun. 329 (2005) 984-990
28. Torres-Padilla M.E., Fougere-Deschatrette C., and Weiss M.C. Expression of HNF4a isoforms in mouse liver development is regulated by sequential promoter usage and constitutive 3′ end splicing. Mech. Dev. 109 (2001) 183-193
29. Petrescu A.D., Hertz R., Bar-Tana J., Schroeder F., and Kier A.B. Role of regulatory F-domain in hepatocyte nuclear factor-4a ligand specificity. J. Biol. Chem. 280 (2005) 16714-16727
30. Petrescu A.D., Payne H.R., Boedecker A., Chao H., Hertz R., Bar-Tana J., Schroeder F., and Kier A.B. Physical and functional interaction of Acyl-CoA-binding protein with hepatocyte nuclear factor-4a. J. Biol. Chem. 278 (2003) 51813-51824
31. Hertz R., Magenheim J., Berman I., and Bar-Tana J. Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4a. Nature 392 (1998) 512-516
32. Hertz R., Kalderon B., Byk T., Berman I., Za'tara G., Mayer R., and Bar-Tana J. Thioesterase activity and acyl-CoA/fatty acid cross-talk of hepatocyte nuclear factor-4a. J. Biol. Chem. 280 (2005) 24451-24461
33. Suaud L., Formstecher P., and Laine B. The activity of the activation function 2 of the human hepatocyte nuclear factor 4 (HNF-4a) is differently modulated by F domains from various origins. Biochem. J. 340 Pt 1 (1999) 161-169
34. Sladek F.M., Ruse Jr. M.D., Nepomuceno L., Huang S.M., and Stallcup M.R. Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4a1. Mol. Cell Biol. 19 (1999) 6509-6522
35. Hadzopoulou-Cladaras M., Kistanova E., Evagelopoulou C., Zeng S., Cladaras C., and Ladias J.A. Functional domains of the nuclear receptor hepatocyte nuclear factor 4. J. Biol. Chem. 272 (1997) 539-550
36. Jiang G., and Sladek F.M. The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor a. J. Biol. Chem. 272 (1997) 1218-1225
37. Briancon N., Bailly A., Clotman F., Jacquemin P., Lemaigre F.P., and Weiss M.C. Expression of the a7 isoform of hepatocyte nuclear factor (HNF) 4 is activated by HNF6/OC-2 and HNF1 and repressed by HNF4a1 in the liver. J. Biol. Chem. 279 (2004) 33398-33408
38. Bailly A., Torres-Padilla M.E., Tinel A.P., and Weiss M.C. An enhancer element 6 kb upstream of the mouse HNF4a1 promoter is activated by glucocorticoids and liver-enriched transcription factors. Nucleic Acids Res. 29 (2001) 3495-3505
39. Briancon N., and Weiss M.C. In vivo role of the HNF4a AF-1 activation domain revealed by exon swapping. EMBO J. 25 (2006) 1253-1262
40. Torres-Padilla M.E., Sladek F.M., and Weiss M.C. Developmentally regulated N-terminal variants of the nuclear receptor hepatocyte nuclear factor 4a mediate multiple interactions through coactivator and corepressor-histone deacetylase complexes. J. Biol. Chem. 277 (2002) 44677-44687
41. Torres-Padilla M.E., and Weiss M.C. Effects of interactions of hepatocyte nuclear factor 4a isoforms with coactivators and corepressors are promoter-specific. FEBS Lett. 539 (2003) 19-23
42. Wang J.C., Stafford J.M., and Granner D.K. SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. J. Biol. Chem. 273 (1998) 30847-30850
43. Drewes T., Senkel S., Holewa B., and Ryffel G.U. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol. Cell Biol. 16 (1996) 925-931
44. Xia Y., Yu P.B., Sidis Y., Beppu H., Bloch K.D., Schneyer A.L., and Lin H.Y. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4. J. Biol. Chem. 282 (2007) 18129-18140
45. Yang F., Agulian T., Sudati J.E., Rhoads D.B., and Levitsky L.L. Developmental regulation of galactokinase in suckling mouse liver by the Egr-1 transcription factor. Pediatr. Res. 55 (2004) 822-829
46. Padgett R.A., Grabowski P.J., Konarska M.M., Seiler S., and Sharp P.A. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55 (1986) 1119-1150
47. Naiki T., Nagaki M., Shidoji Y., Kojima H., Imose M., Kato T., Ohishi N., Yagi K., and Moriwaki H. Analysis of gene expression profile induced by hepatocyte nuclear factor 4alpha in hepatoma cells using an oligonucleotide microarray. J. Biol. Chem. 277 (2002) 14011-14019
48. Singh P., Singh M., Gaur S., and Kaur T. The ApoAI-CIII-AIV gene cluster and its relation to lipid levels in type 2 diabetes mellitus and coronary heart disease: determination of a novel susceptible haplotype. Diab. Vasc. Dis. Res. 4 (2007) 124-129
49. Silander K., Mohlke K.L., Scott L.J., Peck E.C., Hollstein P., Skol A.D., Jackson A.U., Deloukas P., Hunt S., Stavrides G., Chines P.S., Erdos M.R., Narisu N., Conneely K.N., Li C., Fingerlin T.E., Dhanjal S.K., Valle T.T., Bergman R.N., Tuomilehto J., Watanabe R.M., Boehnke M., and Collins F.S. Genetic variation near the hepatocyte nuclear factor-4a gene predicts susceptibility to type 2 diabetes. Diabetes 53 (2004) 1141-1149
50. Johansson S., Raeder H., Eide S.A., Midthjell K., Hveem K., Sovik O., Molven A., and Njolstad P.R. Studies in 3,523 Norwegians and meta-analysis in 11,571 subjects indicate that variants in the hepatocyte nuclear factor 4a (HNF4A) P2 region are associated with type 2 diabetes in Scandinavians. Diabetes 56 (2007) 3112-3117
51. Holmkvist J., Almgren P., Lyssenko V., Lindgren C.M., Eriksson K.F., Isomaa B., Tuomi T., Nilsson P., and Groop L. Common variants in maturity-onset diabetes of the young genes and future risk of type 2 diabetes. Diabetes 57 (2008) 1738-1744
52. Blencowe B.J. Alternative splicing: new insights from global analyses. Cell 126 (2006) 37-47
53. Lareau L.F., Green R.E., Bhatnagar R.S., and Brenner S.E. The evolving roles of alternative splicing. Curr. Opin. Struct. Biol. 14 (2004) 273-282